Procurement Summary
Country: Macedonia
Summary: Drugs on the Hospital List and Commercial Drugs
Deadline: 26 May 2026
Posting Date: 24 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140051761
Document Ref. No.: 07088/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
33600000 - Pharmaceutical products
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
DRUGS ON THE HOSPITAL LIST AND COMMERCIAL DRUGS1 A02BC02 Pantoprazole 40mg, 2 A02BC03 Lansoprazole 30mg", 3 A03BA01 Atropine 1mg/1ml, 4 A03FA01 Metoclopramide (10mg/2ml), 5 A03FA01 Metoclopramide 10m, 6 A04AA01 Ondansetron 2mg/1ml (4mg/2ml, 7 A05AA02 Ursodeoxycholic acid 250mg/5ml, 8 A07AA02 Nystatin 100.000 IE/1ml, 9 A07AX03 Nifuroxazide 200mg, 10 A10AB05 INSULIN ASPART 100 E /1ml 10ml, 11 A10AB05 Insulin aspart 100 E /1ml, 12 A10AC01 Human insulin 100 IE /1ml, 13 A11CC05 Colecalciferol 4000 IE /1 ml, 14 A11DA01 Thiamine 100mg/1ml, 15 A11GA01 ASCORBIC ACID l(500mg/5ml), 16 A11HA02 Pyridoxine 50mg/2ml, 17 B01AB01 Heparin (25000 IE/5ml), 18 B01AB05 ENOXAPARIN originator 2000 IЕ(20mg)/ 0, 2 ml, 19 B01AB05 ENOXAPARIN originator 4000 IE(40mg)/ 0, 4 ml, 20 B01AB05 ENOXAPARIN biosimilar 2000 anti-XaIE/ 0, 2 ml, 21 B01AB05 ENOXAPARIN biosimilar 4000 anti-XaIE/0, 4 ml, 22 B01AB06 NADROPARIN 3800IE anti-Xa /0, 4ml, 23 B01AB06 Nadroparin 2850IE anti-Xa / 0, 3 ml, 24 B01AC06 Acetylsalicylic acid 300mg, 25 B03AA02 Ferrous fumarate 350mg, 26 B03BA01 Cyanocobalamin 500 mcg/1ml, 27 B05AA01 Human Albumin 20% 50ml (20g/100m)l/(0, 2g/1ml)/(200g/1L), 28 B05BA01 Solution for parenteral nutrition, amino acids 10%/100 ml, 29 B05BA02 fat emulsions 20%/100 ml(200mg/1ml), 30 C01AA05 Digoxin 0, 25mg, 31 C01BD01 AMIODARONE 150mg/3ml, 32 C01CA04 DOPAMINE 200mg/5ml, 33 C01CA07 DOBUTAMINE 250mg/20ml, 34 C01CA24 EPINEPHRINE 1mg/1ml, 35 C01DA08 Isosorbide dinitrate 5mg, 36 C02CA06 Urapidil 25mg/5 ml, 37 C03AA03 Hydro chlorothiazide 25mg, 38 C03CA01 FURO...
CPV Descriptions: Pharmaceutical products
Documents
Tender Notice
Document_1.docx
Document_2.docx
Document_3.pdf
Document_4.pdf